Taro Pharmaceutical Industries (TARO)

NYSE 2 marketed ·

Quick facts

TickerTARO (NYSE)

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: